Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Asieris Says ReviR Identifies Candidates to Modulate Oncogenic Driver Gene

publication date: Jun 17, 2024

Shanghai Asieris Pharma announced its collaboration with ReviR Therapeutics has identified a novel lead series of small molecules that modulate the expression of an oncogenic driver gene. The molecules, which were part of ReviR's proprietary compound library, can drive inclusion of a cryptic exon into the mRNA of a novel target gene, reducing the disease protein. ReviR, a San Francisco area biotech, develops small molecule RNA splicing modulators for neurogenetic and oncology indications. Asieris develops novel drugs for genitourinary tumors and related diseases. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here